X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (30) 30
male (21) 21
female (16) 16
oncology (16) 16
middle aged (14) 14
adult (12) 12
life sciences (12) 12
aged (11) 11
cancer (10) 10
chemotherapy (10) 10
care and treatment (9) 9
prognosis (9) 9
survival (9) 9
drug therapy (6) 6
medicine & public health (6) 6
metastasis (6) 6
prostate cancer (6) 6
research (6) 6
aged, 80 and over (5) 5
follow-up studies (5) 5
immunology (5) 5
medical prognosis (5) 5
prospective studies (5) 5
risk (5) 5
tumors (5) 5
age (4) 4
analysis (4) 4
anesthesiology (4) 4
clinical neurology (4) 4
enzalutamide (4) 4
history (4) 4
metastases (4) 4
mutation (4) 4
prostate (4) 4
retrospective studies (4) 4
review (4) 4
safety (4) 4
therapy (4) 4
treatment outcome (4) 4
[ sdv ] life sciences [q-bio] (3) 3
anemia (3) 3
animals (3) 3
antineoplastic agents - administration & dosage (3) 3
carcinoma (3) 3
castration (3) 3
clinical trials (3) 3
deoxyribonucleic acid--dna (3) 3
disease-free survival (3) 3
double-blind (3) 3
education (3) 3
emergency medicine (3) 3
france history (3) 3
gene expression (3) 3
genetics (3) 3
guidelines (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
hepcidin (3) 3
inflammation (3) 3
intensive / critical care medicine (3) 3
medicine (3) 3
medicine, general & internal (3) 3
middle-age (3) 3
neoplasm staging (3) 3
neoplasms - drug therapy (3) 3
open-label (3) 3
patients (3) 3
pharmacology & pharmacy (3) 3
population (3) 3
proportional hazards models (3) 3
prostatic neoplasms, castration-resistant - drug therapy (3) 3
renal cell carcinoma (3) 3
reproducibility of results (3) 3
risk assessment (3) 3
risk factors (3) 3
studies (3) 3
surgery (3) 3
survival analysis (3) 3
toxicity (3) 3
urology & nephrology (3) 3
urothelial carcinoma (3) 3
vinblastine (3) 3
young adult (3) 3
1506 (2) 2
[sdv.mhep]life sciences [q-bio]/human health and pathology (2) 2
[sdv]life sciences [q-bio] (2) 2
abiraterone acetate (2) 2
abridged index medicus (2) 2
adults (2) 2
adverse events (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antiviral agents - administration & dosage (2) 2
article (2) 2
association (2) 2
autoimmune diseases (2) 2
biology and life sciences (2) 2
bladder-cancer (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (7) 7
Robarts - Stacks (4) 4
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Trinity College (John W Graham) - Storage (2) 2
Victoria University E.J. Pratt - Storage (2) 2
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's College (John M. Kelly) - Rare Book (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Psychiatry, ISSN 0160-6689, 11/2018, Volume 79, Issue 6
Objective: This large-scale population-based prospective study examined the association between depressive symptoms and cognitive performance at baseline with... 
POPULATION | METAANALYSIS | PSYCHIATRY | DISORDER | DISABILITY | RELIABILITY | DYSFUNCTION | DEFICITS | 1ST-EPISODE | PSYCHOLOGY, CLINICAL | ASSOCIATION | HEALTH SURVEY | Life Sciences
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2018, Volume 89, Issue 10, pp. 1107 - 1115
Journal Article
European Journal of Neurology, ISSN 1351-5101, 07/2016
BACKGROUND AND PURPOSE: The aim of our study was to examine the effect sizes of different cognitive function determinants in middle and early old age. METHODS:... 
Life Sciences | Santé publique et épidémiologie
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S43 - S49
Immunotherapies for urothelial carcinoma: Therapeutic advances in the last 3 decades in bladder cancer were very limited. The 21 century will be more promising... 
inhibitors | Immune checkpoint | Immunotherapy | Vaccine | Urothelial carcinoma
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 06/2015, Volume 102, Issue 6, pp. 501 - 508
Therapeutic arsenal in prostate cancer widens for several years. New hormonal therapies such as acetate abiraterone or enzalutamide were the first molecules to... 
Cabozantinib | Abiraterone | MOSCATO | Enzalutamide | CRPC
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2018, Volume 39, Issue 38, pp. 3553 - 3553
Journal Article
Journal Article
JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN 2051-1426, 10/2019, Volume 7, Issue 1, pp. 266 - 266
Background Nivolumab, a programmed death-1 (PD-1) inhibitor, is an immune checkpoint inhibitor particularly used in the treatment of malignant melanoma,... 
IMMUNE | Corticotherapy | Immune checkpoint inhibitor | ONCOLOGY | Nivolumab | Cardiotoxicity | IMMUNOLOGY | Immune-related adverse event | ADVERSE EVENTS | IPILIMUMAB | Pericardial effusion | Tamponade | Complications and side effects | Care and treatment | Lymphocytes | Ipilimumab | Immunotherapy | Melanoma | Carboplatin | Lung cancer, Non-small cell | Pemetrexed | Index Medicus
Journal Article
by Petrylak, Daniel and Petrylak, Daniel P and de Wit, Ronald and Chi, Kim Nguyen and Chi, Kim N and Drakaki, Alexandra and Sternberg, Cora N and Nishiyama, Hiroyuki and Castellano, Daniel and Hussain, Syed and Fléchon, Aude and Bamias, Aristotelis and Yu, Evan Y and van der Heijden, Michiel S and Matsubara, Nobuaki and Alekseev, Boris and Necchi, Andrea and Géczi, Lajos and Ou, Yen-Chuan and Coskun, Hasan Senol and Su, Yu-Li and Su, Wen-Pin and Hegemann, Miriam and Percent, Ivor and Percent, Ivor J and Lee, Yun-Gyoo and Lee, Hyo Jin and Lee, Jae-Lyun and Tucci, Marcello and Semenov, Andrey and Laestadius, Fredrik and Peer, Avivit and Tortora, Giampaolo and Safina, Sufia Z and Safina, Sufia and del Muro, Xavier Garcia and Rodriguez-Vida, Alejo and Cicin, Irfan and Harputluoglu, Hakan and Widau, Ryan C and Liepa, Astra M and Walgren, Richard A and Hamid, Oday and Zimmermann, Annamaria H and Bell-McGuinn, Katherine M and Powles, Thomas and Wong, Suet-Lai Shirley and Tan, Thean Hsiang and Hovey, Elizabeth Jane and Clay, Timothy Dudley and Ng, Siobhan Su Wan and Rutten, Annemie and Machiels, Jean-Pascal and Dumez, Herlinde and Cheng, Susanna Yee-Shan and Ferrario, Cristiano and Sengeloev, Lisa and Jensen, Niels Viggo and Thibault, Constance and Laguerre, Brigitte and Joly, Florence and Flechon, Aude and Culine, Stéphane and Becht, Catherine and Niegisch, Günter and Stöckle, Michael and Grimm, Marc-Oliver and Gakis, Georgios and Schultze-Seemann, Wolfgang and Kalofonos, Haralambos and Mavroudis, Dimitrios and Papandreou, Christos and Karavasilis, Vasilis and Révész, Janos and Geczi, Lajos and Rosenbaum, Eli and Leibowitz-Amit, Raya and Kejzman, Daniel and Sarid, David and Scagliotti, Giorgio Vittorio and Bracarda, Sergio and Massari, Francesco and Osawa, Takahiro and Miyajima, Naoto and Shinohara, Nobuo and Fukuta, Fumimasa and Ohyama, Chikara and Obara, Wataru and Yamashita, Shinichi and Tomita, Yoshihiko and Kawai, Koji and Fukasawa, Satoshi and Oyama, Masafumi and Yonese, Junji and Nagata, Masayoshi and Uemura, Motohide and Nishimura, Kazuo and Kawakita, Mutsushi and Tsunemori, Hiroyuki and Hashine, Katsuyoshi and ... and RANGE Study Investigators and RANGE study investigators
The Lancet, ISSN 0140-6736, 11/2017, Volume 390, Issue 10109, pp. 2266 - 2277
Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed... 
BLADDER-CANCER | MEDICINE, GENERAL & INTERNAL | 2ND-LINE THERAPY | TRANSITIONAL-CELL-CARCINOMA | CISPLATIN | DOXORUBICIN | METHOTREXATE | VINBLASTINE | OPEN-LABEL | COMBINATION | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Transitional Cell - mortality | Prognosis | Humans | Middle Aged | Male | Neoplasm Invasiveness - pathology | Urinary Bladder Neoplasms - pathology | Adult | Female | Urinary Bladder Neoplasms - mortality | Double-Blind Method | Risk Assessment | Docetaxel | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Carcinoma, Transitional Cell - pathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Internationality | Neoadjuvant Therapy - methods | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Neoplasm Staging | Antimitotic agents | Care and treatment | Carcinoma | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Cancer | Cytotoxicity | Oncology | Patients | Cancer therapies | Metastases | Angiogenesis | Chemotherapy | Platinum | Medical prognosis | Ligands | Clinical medicine | Urothelial carcinoma | Vascular endothelial growth factor | Apoptosis
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S24 - S34
Immunotherapy for Renal Cell Carcinoma: Clear cell kidney cancer is a tumour type whose development and progression is driven by the HIF/VEGF angiogenesis... 
Clear cell renal cell | Immune checkpoint | inhibitor | carcinoma | VEGFR-TKI | PD-1
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 10120 - 10120
Journal Article
Translational Cancer Research, ISSN 2218-676X, 2016, Volume 5, Issue S2, pp. S261 - S263
Journal Article
Journal Article
19.